Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

What Happens After Royal Caribbean Gets a Flush of Cash

By Chris Lau, InvestorPlace Contributor

With Royal Caribbean flush with cash from its debt raise, RCL stock watchers are now eyeing a 2021 tourism rebound.

Delta Is the Best Airline Positioned For a Rebound

By Chris Lau, InvestorPlace Contributor

Delta is cutting costs to get through the coronavirus pandemic. DAL stock needs a single catalyst to take off again.

7 Electronic Payment Stocks to Ring Up For Covid Recovery

By Chris Lau, InvestorPlace Contributor

Electronic payments stocks have benefited from the global lockdown and as it eases, growth in transactions volumes will accelerate.

How AMD Will Beat Its Own Revenue Forecast in 2020

By Chris Lau, InvestorPlace Contributor

Advanced Micro Devices wasn't hurt at all by a modest forecast. Investors continue to have confidence in AMD stock.

Why iBio Stock May Double or Triple in Value

By Chris Lau, InvestorPlace Contributor

IBIO stock is a potentially rewarding stock if customers use its manufacturing processes to scale up production of a Covid-19 vaccine.

Load More